GTHCX Holdings — Invesco Health Care Fund
All 81 reported holdings of Invesco Health Care Fund (GTHCX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly and Co. | 9.65% | $109.19M |
| Johnson & Johnson | 5.85% | $66.13M |
| AstraZeneca PLC | 4.18% | $47.29M |
| Gilead Sciences, Inc. | 3.90% | $44.09M |
| UnitedHealth Group Inc. | 3.79% | $42.86M |
| argenx SE | 3.66% | $41.41M |
| AbbVie Inc. | 3.62% | $40.93M |
| McKesson Corp. | 3.43% | $38.77M |
| Cencora, Inc. | 3.12% | $35.25M |
| Invesco Private Prime Fund | 3.01% | $34.06M |
| Welltower Inc. | 2.31% | $26.18M |
| Merck & Co., Inc. | 2.27% | $25.64M |
| BrightSpring Health Services, Inc. | 2.04% | $23.13M |
| Regeneron Pharmaceuticals, Inc. | 2.02% | $22.86M |
| Royalty Pharma PLC | 1.95% | $22.09M |
| Vertex Pharmaceuticals Inc. | 1.93% | $21.78M |
| Invesco Treasury Portfolio | 1.87% | $21.17M |
| Cardinal Health, Inc. | 1.75% | $19.79M |
| HCA Healthcare, Inc. | 1.68% | $19.02M |
| CVS Health Corp. | 1.65% | $18.70M |
| Axsome Therapeutics, Inc. | 1.61% | $18.22M |
| Insmed Inc. | 1.45% | $16.43M |
| Edwards Lifesciences Corp. | 1.42% | $16.09M |
| U C B S.a. | 1.40% | $15.86M |
| BridgeBio Pharma, Inc. | 1.36% | $15.38M |
| Intuitive Surgical, Inc. | 1.24% | $14.04M |
| Sandoz Group AG | 1.20% | $13.57M |
| Mettler-Toledo International Inc. | 1.18% | $13.38M |
| Guardant Health, Inc. | 1.17% | $13.25M |
| IDEXX Laboratories, Inc. | 1.17% | $13.18M |
| United Therapeutics Corp. | 1.16% | $13.16M |
| Natera, Inc. | 1.16% | $13.14M |
| Invesco Private Government Fund | 1.16% | $13.14M |
| Ascendis Pharma A/S | 1.10% | $12.41M |
| Medline Inc. | 1.04% | $11.77M |
| Invesco Government & Agency Portfolio | 0.98% | $11.05M |
| Madrigal Pharmaceuticals, Inc. | 0.97% | $10.95M |
| Ligand Pharmaceuticals Inc. | 0.93% | $10.47M |
| Galderma Group AG | 0.92% | $10.43M |
| Protagonist Therapeutics, Inc. | 0.91% | $10.29M |
| Halozyme Therapeutics, Inc. | 0.87% | $9.87M |
| Lonza Group AG | 0.81% | $9.15M |
| Encompass Health Corp. | 0.77% | $8.74M |
| Alignment Healthcare, Inc. | 0.77% | $8.66M |
| Revolution Medicines, Inc. | 0.75% | $8.44M |
| Thermo Fisher Scientific Inc. | 0.75% | $8.43M |
| Tenet Healthcare Corp. | 0.73% | $8.25M |
| Ionis Pharmaceuticals, Inc. | 0.71% | $8.02M |
| Globus Medical, Inc. | 0.70% | $7.90M |
| Steris PLC | 0.64% | $7.18M |
| Labcorp Holdings Inc. | 0.63% | $7.13M |
| Quest Diagnostics Inc. | 0.62% | $6.98M |
| LeMaitre Vascular, Inc. | 0.43% | $4.83M |
| Boston Scientific Corp. | 0.42% | $4.70M |
| Arrowhead Pharmaceuticals, Inc. | 0.39% | $4.38M |
| Twist Bioscience Corp. | 0.39% | $4.37M |
| BeOne Medicines Ltd. | 0.34% | $3.83M |
| Repligen Corp. | 0.34% | $3.80M |
| Rapport Therapeutics, Inc. | 0.32% | $3.64M |
| Medpace Holdings, Inc. | 0.32% | $3.63M |
| Heartflow, Inc. | 0.32% | $3.61M |
| RadNet, Inc. | 0.31% | $3.55M |
| TransMedics Group, Inc. | 0.30% | $3.39M |
| Stryker Corp. | 0.30% | $3.36M |
| Nuvalent, Inc. | 0.29% | $3.33M |
| Tarsus Pharmaceuticals, Inc. | 0.28% | $3.22M |
| BioLife Solutions, Inc. | 0.28% | $3.20M |
| GeneDx Holdings Corp. | 0.28% | $3.19M |
| Cytokinetics, Inc. | 0.27% | $3.08M |
| Dianthus Therapeutics, Inc. | 0.26% | $2.95M |
| Xenon Pharmaceuticals Inc. | 0.26% | $2.95M |
| Mirum Pharmaceuticals, Inc. | 0.26% | $2.92M |
| Palvella Therapeutics, Inc. | 0.24% | $2.67M |
| Cogent Biosciences, Inc. | 0.23% | $2.66M |
| Rhythm Pharmaceuticals, Inc. | 0.22% | $2.50M |
| Bio-Techne Corp. | 0.22% | $2.48M |
| Abivax S.A. | 0.20% | $2.21M |
| Charles River Laboratories International, Inc. | 0.19% | $2.18M |
| Caris Life Sciences, Inc. | 0.19% | $2.10M |
| Phathom Pharmaceuticals, Inc. | 0.18% | $2.07M |
| BillionToOne, Inc. | 0.10% | $1.11M |
GTHCX overview: performance, fees, allocation and SEC filings